SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hoogervorst, E L.
Right arrow Articles by Uitdehaag, B M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoogervorst, E L.
Right arrow Articles by Uitdehaag, B M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability

E LJ Hoogervorst

Department of Neurology, VU Medical Center, Amsterdam, The Netherlands, e.hoogervorst{at}vumc.nl

J NP Zwemmer

Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

B Jelles

Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

C H Polman

Department of Neurology, VU Medical Center, Amsterdam, The Netherlands

B MJ Uitdehaag

Department of Neurology, VU Medical Center, Amsterdam, The Netherlands, Department of Clinical Epidemiology and Biostatistics, VU Medical Center, Amsterdam, The Netherlands

Objective: To validate the newly developed Multiple Sclerosis Impact Scale (MSIS-29) in a large, well characterized, independent group of MS patients by investigating the relation between the MSIS-29 and the Guy’s Neurological Disability Scale (GNDS), the Expanded Disability Status Scale (EDSS) and the MS Functional Composite (MSFC). Methods: Two hundred MS patients were recruited at our outpatient department. At the same visit GNDS, EDSS, MSFC and MSIS-29 were assessed. Data obtained from GNDS, EDSS and MSFC assessment were compared to both physical and psychological impact scores of the MSIS-29. In addition the contribution of GNDS subcategories, EDSS functional systems and MSFC components to the physical and psychological impact scores of the MSIS-29 was studied. Results: Median scores were 37.5 for the physical and 22.2 for the psychological impact score of the MSIS-29, 13.0 for GNDS and 4.0 for EDSS. Mean MSFC was 0.07. The physical impact score showed good correlations with both GNDS (0.79) and EDSS (0.68) and a moderate correlation with the MSFC (- 0.53). The psychological impact score showed weak correlations with EDSS (0.22) and MSFC (-0.30) and a moderately strong correlation with the GNDS (0.58). In 50 (25%) patients, scores on physical and psychological impact scales diverted, i.e., a relative high score on one scale combined with a relative low score on the other scale. This was related to the clinical disease course. Conclusion: Our study supports the use of the MSIS-29 as a measure for the assessment of physical impact of MS on normal daily life. In addition, our data provides a deeper understanding of the factors that determine both physical and psychological disease impact. Discrepancies between the latter two aspects deserve further attention.

Key Words: disability • MS • MSIS-29 • validation

Multiple Sclerosis, Vol. 10, No. 5, 569-574 (2004)
DOI: 10.1191/1352458504ms1078oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
O. Gray, G. McDonnell, and S. Hawkins
Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study
Multiple Sclerosis, January 1, 2009; 15(1): 75 - 80.
[Abstract] [PDF]


Home page
Mult SclerHome page
L. Costelloe, K. O'Rourke, C. McGuigan, C. Walsh, N. Tubridy, and M. Hutchinson
The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite
Multiple Sclerosis, March 1, 2008; 14(2): 255 - 258.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L. Costelloe, K. O'Rourke, H. Kearney, C. McGuigan, L. Gribbin, M. Duggan, L. Daly, N. Tubridy, and M. Hutchinson
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 841 - 844.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. de Groot, H. Beckerman, B. M. J. Uitdehaag, H. C. W. de Vet, G. J. Lankhorst, C. H. Polman, and L. M. Bouter
The usefulness of evaluative outcome measures in patients with multiple sclerosis
Brain, October 1, 2006; 129(10): 2648 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J C Hobart, A Riazi, D L Lamping, R Fitzpatrick, and A J Thompson
How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales
J. Neurol. Neurosurg. Psychiatry, November 1, 2005; 76(11): 1539 - 1543.
[Abstract] [Full Text] [PDF]


Home page
Chronic IllnessHome page
C. Heffernan and C. Jenkinson
Review Paper: Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions
Chronic Illness, June 1, 2005; 1(2): 131 - 142.
[Abstract] [PDF]



Advertisement